A clinical review published in the journal Pediatrics by the American Academy of Pediatrics addressed this directly, stating that the risk of both micronutrient and macronutrient deficiency in children on GLP-1 medications needs to be better characterized, and that careful monitoring of nutritional intake is recommended for every child on these medications
GLP-1 medications, by contrast, are designed for long-term use and are often continued indefinitely as part of an ongoing weight management plan
In patients with MS, the novel CB2-selective agonist COR167 reduced the proliferation of both peripheral blood mononuclear cells (PBMCs) and myelin basic protein-reactive T cells in a dose-dependent manner [126]
Can occur with Synjardy: lactic acidosis (increased acid level in your blood) Can occur with Jardiance: no unique serious side effects Can occur with both Synjardy and Jardiance: severe allergic reaction Fourniers gangrene (severe infection near your genitals) hypoglycemia (low blood sugar level) increased low-density lipoprotein (LDL) cholesterol level ketoacidosis (a buildup of ketones in your body, which causes your blood to become too acidic) low level of fluid in the body serious UTIs, including pyelonephritis (infection that affects your kidneys) and urosepsis (infection that affects your bloodstream) Effectiveness The use of Synjardy and Jardiance in treating type 2 diabetes has been directly compared in a clinical study
Does microdosing GLP-1 drugs still lead to weight loss
In rare cases where GLP-1 causes intolerable reflux despite all interventions, your provider may recommend discontinuationbut this is not the typical outcome
